SANDOGLOBULIN Side Effects

7039350-1 | Infection, Myalgia
on Aug 31, 2010 Male patient from FRANCE , 57 years of age, was diagnosed with encephalitis (What is encephalitis?) and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), myalgia. Sandoglobulin dosage: Intravenous. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), NOVOLOG (View Novolog Review and Novolog Label ), ALISKIREN (ALISKIREN) (View Aliskiren (aliskiren) Review and Aliskiren (aliskiren) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), EUPRESSYL (URAPIDIL) (View Eupressyl (urapidil) Review and Eupressyl (urapidil) Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6668716-4 | Acute Myocardial Infarction, Acute Pulmonary Oedema, Cardiac Failure, Condition Aggravated, Hypertension, Hypoxia, Infusion Related Reaction, Myocardial Ischaemia, Renal Failure Acute
Patient was taking Sandoglobulin (View Usage). Patient had the following side effects: acute myocardial infarction, acute pulmonary oedema, cardiac failure, condition aggravated, hypertension, hypoxia, infusion related reaction, myocardial ischaemia, renal failure acute on Mar 05, 2010 from BELGIUM Additional patient health information: Male patient , 65 years of age, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and. Sandoglobulin dosage: 0.4 G/kg For 5 Days, Intravenous. During the same period patient was treated with CANDESTARTAN (CANDESARTAN) (View Candestartan (candesartan) Review and Candestartan (candesartan) Label ), ROSEMIDE (FUROSEMIDE) (View Rosemide (furosemide) Review and Rosemide (furosemide) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).

6668701-2 | Localised Oedema
Adverse event was reported on Mar 05, 2010 by a Male patient taking Sandoglobulin (View Usage) (Dosage: 33g, 51g Planned/33g Administered, 12g, 3g) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , 15 years of age, After Sandoglobulin was administered, patient had the following side effects: localised oedema. Patient was hospitalized.

6311481-0 | Bone Marrow Failure, Pancytopenia, Sepsis
on Jul 29, 2009 Female patient from EL SALVADOR , 61 years of age, was diagnosed with autoimmune thrombocytopenia and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, pancytopenia, sepsis (What is sepsis?). Sandoglobulin dosage: 28 G/day, 6 G. During the same period patient was treated with BLOOD TRANSFUSION, AUXILIARY PRODUCTS (BLOOD TRANSFUSION, AUXILIARY PR (View Blood Transfusion, Auxiliary Products (blood Transfusion, Auxiliary Pr Review and Blood Transfusion, Auxiliary Products (blood Transfusion, Auxiliary Pr Label ), CEFTAZIDIM SANDOZ (CEFTAZIDIME) (View Ceftazidim Sandoz (ceftazidime) Review and Ceftazidim Sandoz (ceftazidime) Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.


6237710-X | Bone Marrow Failure, Sepsis
on Jun 04, 2009 Female patient from EL SALVADOR , 58 years of age, was diagnosed with thrombocytopenic purpura and was treated with Sandoglobulin (View Usage). Patient had the following side effects: bone marrow failure, sepsis (What is sepsis?). Sandoglobulin dosage: . Patient was hospitalized.

6194236-X | Bone Marrow Failure, Pancytopenia, Sepsis
Patient was taking Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: bone marrow failure, pancytopenia, sepsis (What is sepsis?) on May 04, 2009 from EL SALVADOR Additional patient health information: Female patient , 58 years of age, was diagnosed with autoimmune thrombocytopenia and. Sandoglobulin dosage: . Patient was hospitalized.

6158909-7 | Atelectasis, Blood Creatine Phosphokinase Increased, Hyponatraemia, Myalgia, Renal Failure Acute
Adverse event was reported on Apr 07, 2009 by a Male patient taking Sandoglobulin (View Usage) (Dosage: See Image) was diagnosed with kawasaki's disease and. Location: FRANCE , weighting 50.71 lb, Patient experienced the following unwanted or unexpected effects: atelectasis, blood creatine phosphokinase increased, hyponatraemia, myalgia, renal failure acute. During the same period patient was treated with IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

6058318-5 | Abdominal Pain, Chills, Hypertension, Pyrexia
on Jan 16, 2009 Female patient from FRANCE , 77 years of age, was diagnosed with peripheral motor neuropathy and was treated with Sandoglobulin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), chills, hypertension, pyrexia. Sandoglobulin dosage: Iv. Patient was hospitalized.

6005607-6 | Abdominal Pain, Bacterial Infection, Blood Culture Positive, Chills, Headache, Muscle Spasms, Neck Pain, Pyrexia, Vomiting
on Nov 27, 2008 Female patient from FRANCE , 33 years of age, weighting 145.5 lb, was diagnosed with muscular weakness and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bacterial infection (What is bacterial infection?), blood culture positive, chills, headache (What is headache?), muscle spasms, neck pain, pyrexia, vomiting. Sandoglobulin dosage: 24 G Daily Iv, Iv. Patient was hospitalized.

5921818-X | Abdominal Pain, Dialysis, Diarrhoea, Headache, Metabolic Acidosis, Nausea, Renal Failure Acute, Renal Tubular Necrosis
Patient was taking Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dialysis (What is dialysis?), diarrhoea, headache (What is headache?), metabolic acidosis, nausea (What is nausea?), renal failure acute, renal tubular necrosis on Sep 16, 2008 from FRANCE Additional patient health information: Male patient , 56 years of age, weighting 180.8 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Sandoglobulin dosage: Ni; 24 G Daily Iv; 36 G Daily Iv. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), APROVEL (View Aprovel Review and Aprovel Label ), MOPRAL (View Mopral Review and Mopral Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5873275-X | Acute Hepatic Failure, Biliary Dilatation, Biliary Tract Disorder, Cholestasis, Hepatic Congestion, Hepatic Fibrosis, Hepatic Necrosis, Hepatic Steatosis, Hepatitis
Adverse event was reported on Aug 19, 2008 by a Male patient taking Sandoglobulin (View Usage) (Dosage: Ni Iv, 12 G Once Iv, 6 G Once Iv) was diagnosed with dermatomyositis and. Location: GERMANY , 59 years of age, weighting 194.0 lb, Patient had the following side effects: acute hepatic failure, biliary dilatation, biliary tract disorder, cholestasis, hepatic congestion, hepatic fibrosis, hepatic necrosis, hepatic steatosis, hepatitis (What is hepatitis?). During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), AZATHIOPRIN (View Azathioprin Review and Azathioprin Label ).

5853474-3 | Acute Hepatic Failure, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Cholestasis, Coagulation Factor V Level Decreased, Coagulopathy, Hepatic Congestion, Hepatic Fibrosis, Hepatic Necrosis
on Aug 05, 2008 Male patient from GERMANY , 59 years of age, weighting 194.0 lb, was diagnosed with dermatomyositis and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: acute hepatic failure, blood bilirubin increased, blood lactate dehydrogenase increased, cholestasis, coagulation factor v level decreased, coagulopathy, hepatic congestion, hepatic fibrosis, hepatic necrosis. Sandoglobulin dosage: Iv; 12 G Once, Iv; 6 G Once, Iv;.

5794505-9 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Sodium Decreased, Diarrhoea, Dyspepsia, Epistaxis, Fatigue, Nystagmus
on Jun 11, 2008 Male patient from FRANCE , 21 years of age, was diagnosed with opsoclonus myoclonus and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood sodium decreased, diarrhoea, dyspepsia, epistaxis, fatigue, nystagmus. Sandoglobulin dosage: 34 G Daily Iv; Iv. During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ). Patient was hospitalized.

5781773-2 | Hepatitis C, Therapeutic Product Contamination, Transmission Of An Infectious Agent Via A Medicinal Product
Patient was taking Sandoglobulin (View Usage). Patient had the following side effects: hepatitis c (What is hepatitis c?), therapeutic product contamination, transmission of an infectious agent via a medicinal product on Jun 10, 2008 from GERMANY Additional patient health information: Female patient , 17 years of age, . Sandoglobulin dosage: Iv.

5708747-1 | Blood Pressure Systolic Increased, Bronchospasm, Chills, Electrocardiogram St Segment Elevation, Hyperthermia, Infusion Related Reaction, Myocardial Infarction, Tachycardia
Adverse event was reported on Mar 26, 2008 by a Female patient taking Sandoglobulin (View Usage) (Dosage: Iv;) . Location: FRANCE , 53 years of age, After Sandoglobulin was administered, patient had the following side effects: blood pressure systolic increased, bronchospasm, chills, electrocardiogram st segment elevation, hyperthermia, infusion related reaction, myocardial infarction, tachycardia. Patient was hospitalized.

5708718-5 | Blood Pressure Systolic Increased, Bronchospasm, Chest Pain, Chills, Hyperthermia, Myocardial Infarction, Tachycardia
on Apr 02, 2008 Female patient from FRANCE , 53 years of age, was diagnosed with gammopathy, non-hodgkin's lymphoma and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, bronchospasm, chest pain (What is chest pain?), chills, hyperthermia, myocardial infarction, tachycardia. Sandoglobulin dosage: 10 G, Daily; Iv. Patient was hospitalized.

5650207-0 | Myocardial Infarction, Pulmonary Embolism, Sinus Tachycardia
on Feb 19, 2008 Female patient from FRANCE , 38 years of age, was diagnosed with muscular weakness and was treated with Sandoglobulin (View Usage). Patient had the following side effects: myocardial infarction, pulmonary embolism (What is pulmonary embolism?), sinus tachycardia. Sandoglobulin dosage: 10 G,once,iv,iv,iv. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ), MESTINON (View Mestinon Review and Mestinon Label ), LIORESAL (View Lioresal Review and Lioresal Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5581309-5 | Anxiety, Pallor, Tremor
Patient was taking Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: anxiety (What is anxiety?), pallor, tremor on Dec 18, 2007 from POLAND Additional patient health information: Female patient , weighting 28.66 lb, was diagnosed with blood immunoglobulin g decreased and. Sandoglobulin dosage: 5 G Daily Iv.

5549020-4 | Anxiety, Erythema, Tremor
Adverse event was reported on Nov 06, 2007 by a Female patient taking Sandoglobulin (View Usage) (Dosage: 5 G Daily Iv) was diagnosed with blood immunoglobulin g decreased and. Location: POLAND , weighting 28.66 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), erythema, tremor.

5511043-9 | Anxiety, Erythema, Tremor
on Oct 29, 2007 Female patient from POLAND , weighting 28.66 lb, was diagnosed with blood immunoglobulin g decreased and was treated with Sandoglobulin (View Usage). Patient had the following side effects: anxiety (What is anxiety?), erythema, tremor. Sandoglobulin dosage: 5 G Daily Iv.

5507298-7 | Chills, Dyspnoea, Hypersensitivity, Infusion Related Reaction, Tachycardia
on Oct 12, 2007 Female patient from GERMANY , 78 years of age, weighting 143.3 lb, was diagnosed with hypogammaglobulinaemia, infection (What is infection?) and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: chills, dyspnoea, hypersensitivity, infusion related reaction, tachycardia. Sandoglobulin dosage: 5 G Once Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NORVASC /00972401/ (View Norvasc /00972401/ Review and Norvasc /00972401/ Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), CONCOR /01166101/ (View Concor /01166101/ Review and Concor /01166101/ Label ), MUCOSOLVAN /00546001/ (View Mucosolvan /00546001/ Review and Mucosolvan /00546001/ Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), LASIX (View Lasix Review and Lasix Label ).

5369831-8 | Abdominal Pain, Bacterial Infection, Blood Culture Positive, Chills, Gram Stain Negative, Headache, Muscle Spasms, Neck Pain, Pyrexia
Patient was taking Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), bacterial infection (What is bacterial infection?), blood culture positive, chills, gram stain negative, headache (What is headache?), muscle spasms, neck pain, pyrexia on Jun 05, 2007 from FRANCE Additional patient health information: Female patient , 33 years of age, weighting 145.5 lb, was diagnosed with muscular weakness and. Sandoglobulin dosage: Iv. Patient was hospitalized.

5368437-4 | Acinetobacter Infection, Blood Pressure Increased, Catheter Sepsis, Dizziness, Enterobacter Infection, Heart Rate Increased, Livedo Reticularis, Oxygen Saturation Decreased, Serratia Infection
Adverse event was reported on Jun 04, 2007 by a Male patient taking Sandoglobulin (View Usage) (Dosage: See Image) was diagnosed with neuropathy peripheral and. Location: FRANCE , 61 years of age, Patient had the following side effects: acinetobacter infection, blood pressure increased, catheter sepsis, dizziness (What is dizziness?), enterobacter infection, heart rate increased, livedo reticularis, oxygen saturation decreased, serratia infection. During the same period patient was treated with DIANTALVIC (View Diantalvic Review and Diantalvic Label ), IMOVANE (View Imovane Review and Imovane Label ), DIFFU K (View Diffu K Review and Diffu K Label ).

5302337-0 | Cytomegalovirus Infection, Headache, Lumbar Puncture Abnormal, Meningitis, Meningitis Bacterial, Nausea, Phonophobia, Photophobia, Platelet Count Decreased
on Mar 26, 2007 Female patient from FRANCE , 41 years of age, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), headache (What is headache?), lumbar puncture abnormal, meningitis (What is meningitis?), meningitis bacterial, nausea (What is nausea?), phonophobia, photophobia, platelet count decreased. Sandoglobulin dosage: . Patient was hospitalized.

5266838-6 | Acquired Immunodeficiency Syndrome, Factor Viii Inhibition, Hepatitis A, Hepatitis B, Hepatitis C, Hiv Test Positive, Therapeutic Product Contamination
on Feb 12, 2007 Male patient from UNITED KINGDOM , child 2 years of age, was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: acquired immunodeficiency syndrome, factor viii inhibition, hepatitis a (What is hepatitis a?), hepatitis b (What is hepatitis b?), hepatitis c (What is hepatitis c?), hiv test positive (What is hiv test positive?), therapeutic product contamination. Sandoglobulin dosage: . During the same period patient was treated with WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ), HEMOFIL (View Hemofil Review and Hemofil Label ), FACTOR VIII (BAYER, CUTTER, BAXTER) (View Factor Viii (bayer, Cutter, Baxter) Review and Factor Viii (bayer, Cutter, Baxter) Label ).

5258255-X | Chills, Malaise, Tachycardia
Patient was taking Sandoglobulin (View Usage). Patient had the following side effects: chills, malaise, tachycardia on Feb 22, 2007 from GERMANY Additional patient health information: Female patient , 72 years of age, weighting 154.3 lb, was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and. Sandoglobulin dosage: 10 G Once Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RANTUDIL (View Rantudil Review and Rantudil Label ).

5223608-2 | Back Pain, Feeling Cold, Livedo Reticularis, Tachycardia
Adverse event was reported on Jan 12, 2007 by a Female patient taking Sandoglobulin (View Usage) (Dosage: 400 Mg/kg Qd Iv) was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and. Location: FRANCE , 70 years of age, After Sandoglobulin was administered, patient had the following side effects: back pain (What is back pain?), feeling cold, livedo reticularis, tachycardia. Patient was hospitalized.

5175349-8 | Blood Pressure Decreased, Chills, Culture Urine Positive, Diarrhoea, Disseminated Intravascular Coagulation, Escherichia Bacteraemia, Haemodialysis, Hepatic Failure, Inflammation
on Nov 13, 2006 Female patient from FRANCE , 70 years of age, was diagnosed with polyneuropathy, radiculopathy and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chills, culture urine positive, diarrhoea, disseminated intravascular coagulation, escherichia bacteraemia, haemodialysis, hepatic failure, inflammation. Sandoglobulin dosage: See Image. Patient was hospitalized.

5158086-5 | Blood Pressure Decreased, Cardiovascular Disorder, Cyanosis, Dyspnoea, Feeling Hot, Infusion Related Reaction, Nausea, Tachycardia
on Nov 07, 2006 Female patient from GERMANY , 72 years of age, weighting 145.5 lb, was diagnosed with selective igg subclass deficiency and was treated with Sandoglobulin (View Usage). Patient had the following side effects: blood pressure decreased, cardiovascular disorder, cyanosis, dyspnoea, feeling hot, infusion related reaction, nausea (What is nausea?), tachycardia. Sandoglobulin dosage: 10 G Q2w Iv; 6 G Daily Iv. During the same period patient was treated with BERLTHYROX (View Berlthyrox Review and Berlthyrox Label ), PLASTUFER (View Plastufer Review and Plastufer Label ), CALCIUM 500 HEXAL (View Calcium 500 Hexal Review and Calcium 500 Hexal Label ), ACC (View Acc Review and Acc Label ), FURORESE (View Furorese Review and Furorese Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), TROMCARDIN (View Tromcardin Review and Tromcardin Label ). Patient was hospitalized.

5158067-1 | Agitation, Shock
Patient was taking Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: agitation, shock on Nov 03, 2006 from FRANCE Additional patient health information: Male patient , child 7 years of age, weighting 63.93 lb, was diagnosed with haemorrhage, thrombocytopenic purpura and. Sandoglobulin dosage: 60 Ml Daily, Iv.

5151919-8 | Dyspnoea, Renal Failure Acute
Adverse event was reported on Oct 27, 2006 by a Male patient taking Sandoglobulin (View Usage) (Dosage: See Image) was diagnosed with multifocal motor neuropathy and. Location: GERMANY , 77 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: dyspnoea, renal failure acute. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

5129220-8 | Bacterial Infection, Blood Culture Positive, Blood Pressure Decreased, Culture Urine Positive, Diarrhoea, Disseminated Intravascular Coagulation, Haemodialysis, Hepatic Failure, Inflammation
on Sep 29, 2006 Female patient from FRANCE , 70 years of age, was diagnosed with neuritis, radiculopathy and was treated with Sandoglobulin (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood culture positive, blood pressure decreased, culture urine positive, diarrhoea, disseminated intravascular coagulation, haemodialysis, hepatic failure, inflammation. Sandoglobulin dosage: 22 G Daily Iv. Patient was hospitalized.

5129208-7 | Enterobacter Infection, Hyperthermia, Infusion Related Reaction, Sepsis, Staphylococcal Infection
on Sep 15, 2006 Female patient from FRANCE , 48 years of age, was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: enterobacter infection, hyperthermia, infusion related reaction, sepsis (What is sepsis?), staphylococcal infection (What is staphylococcal infection?). Sandoglobulin dosage: 12 G Daily Iv. Patient was hospitalized.

5118493-3 | Blood Pressure Decreased, Cardiovascular Disorder, Cyanosis, Dyspnoea, Feeling Hot, Infusion Related Reaction, Nausea, Tachycardia
Patient was taking Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiovascular disorder, cyanosis, dyspnoea, feeling hot, infusion related reaction, nausea (What is nausea?), tachycardia on Sep 15, 2006 from GERMANY Additional patient health information: Female patient , 72 years of age, weighting 145.5 lb, was diagnosed with selective igg subclass deficiency and. Sandoglobulin dosage: See Image. During the same period patient was treated with BERLTHYROX (View Berlthyrox Review and Berlthyrox Label ), PLASTUFER (View Plastufer Review and Plastufer Label ), CALCIUM 500 HEXAL (View Calcium 500 Hexal Review and Calcium 500 Hexal Label ), ACC /00082801/ (View Acc /00082801/ Review and Acc /00082801/ Label ), FURORESE (View Furorese Review and Furorese Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), TROMCARDIN (View Tromcardin Review and Tromcardin Label ). Patient was hospitalized.

5097105-1 | Abdominal Pain, Dialysis, Diarrhoea, Headache, Metabolic Acidosis, Renal Failure Acute, Renal Tubular Necrosis
Adverse event was reported on Aug 23, 2006 by a Male patient taking Sandoglobulin (View Usage) (Dosage: See Image) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , 56 years of age, weighting 180.8 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), dialysis (What is dialysis?), diarrhoea, headache (What is headache?), metabolic acidosis, renal failure acute, renal tubular necrosis. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), GLUCOPHAGE /00082701/ (View Glucophage /00082701/ Review and Glucophage /00082701/ Label ), APROVEL (View Aprovel Review and Aprovel Label ), MOPRAL (View Mopral Review and Mopral Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5090697-8 | Dialysis, Diarrhoea, Headache, Metabolic Acidosis, Renal Failure Acute, Renal Tubular Necrosis
on Aug 09, 2006 Male patient from FRANCE , 56 years of age, weighting 178.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: dialysis (What is dialysis?), diarrhoea, headache (What is headache?), metabolic acidosis, renal failure acute, renal tubular necrosis. Sandoglobulin dosage: 24 G Daily Iv; 36 G Daily Iv. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), APROVEL (View Aprovel Review and Aprovel Label ), MOPRAL (View Mopral Review and Mopral Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5073123-4 | Abdominal Pain, Anuria, Blood Creatinine Increased, Blood Phosphorus Increased, Blood Urea Increased, Dialysis, Diarrhoea, Headache, Nausea
on Jul 17, 2006 Female patient from FRANCE , 56 years of age, weighting 178.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anuria, blood creatinine increased, blood phosphorus increased, blood urea increased, dialysis (What is dialysis?), diarrhoea, headache (What is headache?), nausea (What is nausea?). Sandoglobulin dosage: 24 + 36 G Daily Iv - See Image. During the same period patient was treated with DAONIL (View Daonil Review and Daonil Label ), GLUCOPHAGE /00082701/ (View Glucophage /00082701/ Review and Glucophage /00082701/ Label ), APROVEL (View Aprovel Review and Aprovel Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

5027790-1 | Oliguria, Renal Tubular Necrosis
Patient was taking Sandoglobulin (View Usage). Patient had the following side effects: oliguria, renal tubular necrosis on Jun 13, 2006 from UNITED STATES Additional patient health information: Male patient , 60 years of age, . Sandoglobulin dosage: .

5023353-2 | Campylobacter Infection, Cytolytic Hepatitis, Hepatitis Acute
Adverse event was reported on May 16, 2006 by a Male patient taking Sandoglobulin (View Usage) (Dosage: 24 G Daily Iv) was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and. Location: FRANCE , 30 years of age, After Sandoglobulin was administered, patient had the following side effects: campylobacter infection, cytolytic hepatitis, hepatitis acute. During the same period patient was treated with NEURONTIN (Po) (View Neurontin Review and Neurontin Label ), CAFEINE (View Cafeine Review and Cafeine Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5010016-2 | Cough, Dermatitis Allergic, Diarrhoea, Pyrexia
on May 03, 2006 Female patient from FRANCE , 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dermatitis allergic, diarrhoea, pyrexia. Sandoglobulin dosage: 30 G Daily Iv. During the same period patient was treated with AMIKLIN (View Amiklin Review and Amiklin Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GLEEVEC (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5000176-1 | Agranulocytosis, Neutropenia, Thrombocytopenia
on Apr 26, 2006 Female patient from FRANCE , 66 years of age, weighting 116.8 lb, was diagnosed with polymyositis and was treated with Sandoglobulin (View Usage). Patient had the following side effects: agranulocytosis, neutropenia, thrombocytopenia. Sandoglobulin dosage: See Image. Patient was hospitalized.

4955260-5 | Agranulocytosis
Patient was taking Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: agranulocytosis on Mar 10, 2006 from FRANCE Additional patient health information: Female patient , 66 years of age, was diagnosed with polymyositis and. Sandoglobulin dosage: See Image, Iv. During the same period patient was treated with MOPRAL (View Mopral Review and Mopral Label ). Patient was hospitalized.

4872797-8 | Hiv Antibody Positive, Seroconversion Test Positive
Adverse event was reported on Dec 14, 2005 by a Female patient taking Sandoglobulin (View Usage) (Dosage: 1 G/kg B.w. Daily) was diagnosed with autoimmune thrombocytopenia and. Location: UNITED KINGDOM , 40 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: hiv antibody positive (What is hiv antibody positive?), seroconversion test positive.

4864962-0 | Seroconversion Test Positive
on Nov 28, 2005 Female patient from UNITED STATES , 40 years of age, weighting 119.0 lb, was diagnosed with autoimmune thrombocytopenia and was treated with Sandoglobulin (View Usage). Patient had the following side effects: seroconversion test positive. Sandoglobulin dosage: 1 G/kg B.w. Daily.

4864961-9 | Arrhythmia, Cardiac Output Decreased, Coronary Artery Stenosis, Dizziness, Fatigue, Hypotension, Infection, Malaise, Myocardial Infarction
on Nov 28, 2005 Female patient from UNITED KINGDOM , 33 years of age, weighting 92.59 lb, was diagnosed with myasthenia gravis and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac output decreased, coronary artery stenosis, dizziness (What is dizziness?), fatigue, hypotension, infection (What is infection?), malaise, myocardial infarction. Sandoglobulin dosage: 18 G Daily Iv. During the same period patient was treated with PHYSOSTIGMINE (View Physostigmine Review and Physostigmine Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ANTI ASTHMATICS (View Anti-asthmatics Review and Anti-asthmatics Label ), PLASMA SUBSTITUTES AND PERFUSION SOLUTIONS (View Plasma Substitutes And Perfusion Solutions Review and Plasma Substitutes And Perfusion Solutions Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ). Patient was hospitalized.

4864954-1 | Seroconversion Test Positive
Patient was taking Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: seroconversion test positive on Dec 08, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 40 years of age, weighting 119.0 lb, was diagnosed with autoimmune thrombocytopenia and. Sandoglobulin dosage: 1 G/kg B.w. Daily.

4846423-8 | Cerebrovascular Accident
Adverse event was reported on May 31, 2005 by a Female patient taking Sandoglobulin (View Usage) (Dosage: 400 Mg/kg) was diagnosed with myasthenia gravis and. Location: UNITED STATES , 27 years of age, Patient had the following side effects: cerebrovascular accident.

4754265-7 | Blood Pressure Increased, Chest Discomfort, Dyspnoea, Feeling Hot
on Aug 03, 2005 Female patient from GERMANY , 80 years of age, weighting 138.9 lb, was diagnosed with secondary immunodeficiency and was treated with Sandoglobulin (View Usage). After Sandoglobulin was administered, patient had the following side effects: blood pressure increased, chest discomfort, dyspnoea, feeling hot. Sandoglobulin dosage: 10 G, Once, I.v.. During the same period patient was treated with ALLOPURINOL 300 (ALLOPURINOL) (View Allopurinol 300 (allopurinol) Review and Allopurinol 300 (allopurinol) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ZOMETA (View Zometa Review and Zometa Label ), BENDAMUSTINE (BENDAMUSTINE0 (View Bendamustine (bendamustine0 Review and Bendamustine (bendamustine0 Label ), KEVATRIL 9GRANISETRON HYDROCHLORIDE) (View Kevatril 9granisetron Hydrochloride) Review and Kevatril 9granisetron Hydrochloride) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

4754264-5 | Blood Pressure Increased, Chills, Heart Rate Increased
on Aug 03, 2005 Female patient from GERMANY , 67 years of age, weighting 108.0 lb, was diagnosed with secondary immunodeficiency and was treated with Sandoglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, chills, heart rate increased. Sandoglobulin dosage: 10 G, Once, I.v.. During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ). Patient was hospitalized.

4754262-1 | Bronchospasm, Dyspnoea, Infusion Related Reaction, Oedema Mucosal, Restlessness
Patient was taking Sandoglobulin (View Usage). Patient had the following side effects: bronchospasm, dyspnoea, infusion related reaction, oedema mucosal, restlessness on Aug 04, 2005 from GERMANY Additional patient health information: Female patient , 28 years of age, weighting 127.9 lb, was diagnosed with immunodeficiency and. Sandoglobulin dosage: 10 G, Once, I.v.. Patient was hospitalized.